News & Press.
Learn the Latest Aziyo Updates
Surgalign Holdings Announce the Commercial Launch of ViBone® Moldable and the First Clinical Implantation
Commercial launch of ViBone® Moldable, a next generation moldable cellular bone matrix product in the US. DEERFIELD, Ill., January 12, 2021 — Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine...
Aziyo Biologics Reports Third Quarter 2020 Financial Results
SILVER SPRING, Md., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients...
Aziyo Biologics to Participate in the Piper 32nd Annual Virtual Healthcare Conference
SILVER SPRING, Md., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients...
Surgalign Holdings and Aziyo Biologics Announce Expanded Distribution Agreement
Updated agreement expands availability of ViBone® Moldable, a next generation moldable cellular bone matrix product DEERFIELD, Ill. and Silver Spring, Md, Nov. 16, 2020 -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company...
Aziyo Biologics Awarded Breakthrough Technology Contract with Premier Inc.
SILVER SPRING, Md. – November 12, 2020 – Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, has...